Gene Synthesis Proligo Rules DNA Bases Lock, Stock, and Barrel | GenomeWeb

It’s still a fairly small and young company, but Proligo, with joint offices in Hamburg, Germany, and Boulder, Colo., has already declared itself indispensable in the genomics arena. With key patents in DNA synthesis, the company is a virtual gatekeeper for people looking to make primers or any other strings of As, Cs, Ts, and Gs. “We manufacture those monomers … at a multi-ton level,” says Wolfgang Pieken, president and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.